Molina Healthcare (NYSE:MOH) Rating Increased to Hold at Royal Bank Of Canada

Molina Healthcare (NYSE:MOH) was upgraded by research analysts at Royal Bank Of Canada to a “hold” rating in a research note issued to investors on Tuesday,Zacks.com reports.

Several other equities analysts have also recently weighed in on the stock. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Molina Healthcare in a research note on Tuesday, April 21st. Truist Financial lifted their price objective on shares of Molina Healthcare from $180.00 to $205.00 and gave the stock a “hold” rating in a research note on Monday, May 11th. Bank of America upgraded shares of Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 target price on the stock in a report on Wednesday, April 29th. Sanford C. Bernstein reaffirmed an “outperform” rating on shares of Molina Healthcare in a report on Friday, March 13th. Finally, Mizuho set a $215.00 price objective on Molina Healthcare in a research report on Monday, June 8th. Three research analysts have rated the stock with a Buy rating, twelve have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $184.81.

Molina Healthcare Stock Down 0.6%

NYSE MOH opened at $196.18 on Tuesday. Molina Healthcare has a 52 week low of $121.06 and a 52 week high of $311.52. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.97. The company has a market capitalization of $10.22 billion, a P/E ratio of 58.04 and a beta of 0.80. The stock’s 50-day moving average price is $182.41 and its 200-day moving average price is $167.09.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 EPS for the quarter, beating the consensus estimate of $1.57 by $0.78. The business had revenue of $10.80 billion for the quarter, compared to the consensus estimate of $10.91 billion. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.The business’s revenue was down 3.1% on a year-over-year basis. During the same period in the previous year, the business earned $6.08 earnings per share. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. On average, equities research analysts predict that Molina Healthcare will post 5.23 earnings per share for the current year.

Insider Activity

In related news, CAO Maurice Hebert sold 600 shares of the stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $191.55, for a total value of $114,930.00. Following the transaction, the chief accounting officer owned 12,815 shares of the company’s stock, valued at $2,454,713.25. This represents a 4.47% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Jeff D. Barlow sold 17,811 shares of the firm’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $186.12, for a total value of $3,314,983.32. Following the transaction, the insider owned 67,175 shares in the company, valued at $12,502,611. The trade was a 20.96% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 1.44% of the company’s stock.

Institutional Trading of Molina Healthcare

A number of hedge funds have recently bought and sold shares of the stock. AQR Capital Management LLC lifted its position in shares of Molina Healthcare by 217.0% during the third quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company’s stock valued at $561,475,000 after buying an additional 2,008,458 shares during the last quarter. T. Rowe Price Investment Management Inc. grew its position in shares of Molina Healthcare by 10.2% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 2,171,433 shares of the company’s stock worth $376,831,000 after buying an additional 201,772 shares during the last quarter. Invesco Ltd. raised its stake in shares of Molina Healthcare by 24.2% during the 4th quarter. Invesco Ltd. now owns 1,690,981 shares of the company’s stock worth $293,453,000 after acquiring an additional 329,679 shares in the last quarter. Victory Capital Management Inc. raised its stake in shares of Molina Healthcare by 46.4% during the 4th quarter. Victory Capital Management Inc. now owns 1,410,604 shares of the company’s stock worth $244,796,000 after acquiring an additional 447,078 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its position in Molina Healthcare by 23.7% during the first quarter. Dimensional Fund Advisors LP now owns 1,394,882 shares of the company’s stock valued at $185,929,000 after acquiring an additional 267,121 shares during the last quarter. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.